newsfilter
← Latest News
ACCESS Newswire·

Relief Therapeutics Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing

Proven Pharmaceutical Marketing Leader Brings Extensive Experience in Rare Diseases, Digital Innovation and New Product Launches to Relief's U.S. Commercial Team GENEVA, SWITZERLAND / ACCESSWIRE / April 26, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)